Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) EBT (2017 - 2026)

Neuronetics has reported EBT over the past 10 years, most recently at -$11.3 million for Q1 2026.

  • Quarterly EBT rose 11.43% to -$11.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$38.8 million through Mar 2026, up 15.26% year-over-year, with the annual reading at -$39.9 million for FY2025, 4.77% up from the prior year.
  • EBT was -$11.3 million for Q1 2026 at Neuronetics, down from -$8.0 million in the prior quarter.
  • Over five years, EBT peaked at -$6.3 million in Q4 2023 and troughed at -$13.2 million in Q4 2024.
  • The 5-year median for EBT is -$10.0 million (2025), against an average of -$9.9 million.
  • Year-over-year, EBT tumbled 110.96% in 2024 and then skyrocketed 39.84% in 2025.
  • A 5-year view of EBT shows it stood at -$8.8 million in 2022, then increased by 28.96% to -$6.3 million in 2023, then tumbled by 110.96% to -$13.2 million in 2024, then surged by 39.84% to -$8.0 million in 2025, then plummeted by 41.51% to -$11.3 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's EBT are -$11.3 million (Q1 2026), -$8.0 million (Q4 2025), and -$9.5 million (Q3 2025).